AMAG PHARMACEUTICALS INC's ticker is AMAG and the CUSIP is 00163U106. A total of 211 filers reported holding AMAG PHARMACEUTICALS INC in Q4 2016. The put-call ratio across all filers is 0.42 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $200,000 | +18.3% | 21,256 | -4.1% | 0.00% | 0.0% |
| Q2 2020 | $169,000 | +18.2% | 22,155 | -4.4% | 0.00% | 0.0% |
| Q1 2020 | $143,000 | -51.7% | 23,182 | -4.7% | 0.00% | 0.0% |
| Q4 2019 | $296,000 | +2.4% | 24,334 | -2.6% | 0.00% | 0.0% |
| Q3 2019 | $289,000 | +14.7% | 24,989 | -1.0% | 0.00% | 0.0% |
| Q2 2019 | $252,000 | -24.8% | 25,254 | -2.8% | 0.00% | 0.0% |
| Q1 2019 | $335,000 | -17.3% | 25,977 | -2.6% | 0.00% | -50.0% |
| Q4 2018 | $405,000 | -24.9% | 26,661 | -1.1% | 0.00% | 0.0% |
| Q3 2018 | $539,000 | +4.5% | 26,969 | +2.0% | 0.00% | 0.0% |
| Q2 2018 | $516,000 | +14.2% | 26,442 | +17.9% | 0.00% | 0.0% |
| Q1 2018 | $452,000 | +22.2% | 22,423 | -19.7% | 0.00% | +100.0% |
| Q4 2017 | $370,000 | -27.9% | 27,924 | +0.4% | 0.00% | -50.0% |
| Q3 2017 | $513,000 | +6.2% | 27,802 | +5.9% | 0.00% | 0.0% |
| Q2 2017 | $483,000 | -0.2% | 26,262 | +22.3% | 0.00% | 0.0% |
| Q1 2017 | $484,000 | -45.4% | 21,476 | -15.6% | 0.00% | -33.3% |
| Q4 2016 | $886,000 | -99.9% | 25,453 | -1.4% | 0.00% | 0.0% |
| Q3 2016 | $632,677,000 | +2.1% | 25,813 | -0.3% | 0.00% | 0.0% |
| Q2 2016 | $619,576,000 | +1.1% | 25,902 | -1.2% | 0.00% | +50.0% |
| Q1 2016 | $613,000,000 | +9.9% | 26,206 | +41.9% | 0.00% | 0.0% |
| Q4 2015 | $558,000,000 | +74200.9% | 18,463 | -2.3% | 0.00% | -33.3% |
| Q3 2015 | $751,000 | -99.9% | 18,894 | +3.0% | 0.00% | -40.0% |
| Q2 2015 | $1,266,630,000 | +65.8% | 18,341 | +31.2% | 0.01% | +66.7% |
| Q1 2015 | $764,092,000 | +30.1% | 13,979 | +1.5% | 0.00% | 0.0% |
| Q4 2014 | $587,261,000 | +28.5% | 13,779 | -3.8% | 0.00% | +50.0% |
| Q3 2014 | $457,111,000 | +53.9% | 14,325 | -0.1% | 0.00% | +100.0% |
| Q2 2014 | $297,042,000 | -0.1% | 14,336 | -6.7% | 0.00% | 0.0% |
| Q1 2014 | $297,410,000 | -14.4% | 15,370 | +7.3% | 0.00% | -50.0% |
| Q4 2013 | $347,498,000 | +11.9% | 14,318 | -1.0% | 0.00% | 0.0% |
| Q3 2013 | $310,644,000 | -5.1% | 14,462 | -1.7% | 0.00% | 0.0% |
| Q2 2013 | $327,298,000 | – | 14,710 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| HUNTINGTON NATIONAL BANK | 1 | $14 | 0.00% |